Aldeyra Therapeutics (NasdaqCM:ALDX) 2025 R&D Day Transcript

Aldeyra Therapeutics (NasdaqCM:ALDX) 2025 R&D Day November 13, 2025 08:00 AM ET Company ParticipantsTodd Brady - President and CEOClara Dong - VP of Biotechnology Equity ResearchAdam Lazorchak - Director of Translational Sciences in Non-clinical DevelopmentCatherine Novack - Director of Healthcare Equity ResearchLaura Nichols - Associate Director of Investor RelationsConference Call ParticipantsTom Shrader - Equity Research AnalystNone - AnalystOperatorThank you for your patience on today's call. We are loo ...